Evidence map›Paper›PMID 41783479›Full record

ArticleJournal of chemometrics2025

Cell culture media and Raman spectra preprocessing procedures impact glucose chemometrics.

Naresh Pavurala, Chikkathur N Madhavarao, Jaeweon Lee, Jayanti Das, Muhammad Ashraf, Thomas O'Connor

Abstract read
In one paragraph

Article in Journal of chemometrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Naresh PavuralaDivision II, Office of Pharmaceutical Manufacturing Assessment, CDER, U.S. FDA, Silver Spring, MD, USA.
Chikkathur N MadhavaraoOffice of Pharmaceutical Quality Research, CDER, U.S. FDA, Silver Spring, MD, USA.
Jaeweon LeeOffice of Pharmaceutical Quality Research, CDER, U.S. FDA, Silver Spring, MD, USA.
Jayanti DasOffice of Pharmaceutical Quality Research, CDER, U.S. FDA, Silver Spring, MD, USA.
Muhammad AshrafOffice of Pharmaceutical Quality Research, CDER, U.S. FDA, Silver Spring, MD, USA.
Thomas O'ConnorOffice of Pharmaceutical Quality Research, CDER, U.S. FDA, Silver Spring, MD, USA.

Funding

Intramural FDA HHS FD999999
6 · The paper itself

Abstract

Deployment of process analytical technology tools such as Raman or IR spectroscopy and associated multivariate calibration models for process monitoring and control plays an important role in process automation and advanced manufacturing of pharmaceuticals. Preprocessing or preparation of the spectroscopic data is an important step in developing a multivariate calibration model. There are several ways available to preprocess the data and each may influence the calibration model performance differently. Here we investigated the influence of preprocessing procedures on the development and performance of the chemometric models to predict the glucose concentration in a bioreactor. Box-Behnken design of experiment (DOE) was used to generate the Raman spectroscopy data. Four factors were considered critical in the DOE-glucose, glutamine, glutamic acid, and antifoam concentration. Raman spectroscopy data were collected both with and without aeration conditions, independently from three cell culture media. For each medium, data consisted of calibration set (27 conditions) and model validation set (9 conditions) separately. Additionally, Raman data was also collected for certain DOE runs with increasing concentration of cell densities ranging from 0.5 × 10E06 /mL to 30 × 10E06 /mL under aerating conditions. Data from the three cell culture media were used separately to develop calibration models that used four different preprocessing procedures, namely, baseline correction (BLC), Savitzky-Golay smoothing (SGS), Savitzky-Golay derivative (SGD) and orthogonal signal correction (OSC). The preprocessing procedures were applied individually and in combinations to evaluate the calibration model parameters and the performance metrics. We further developed glucose calibration models based on partial least squares (PLS) regression with 1-3 principal components. The models developed with OSC procedure gave superior performance metrics with just 1 principal component across all three media. Models developed with other preprocessing procedures required two or more principal components to give comparable performance. Overall, the choice of preprocessing procedures affected the model performance.

Indexed as

Baseline CorrectionCHO Cell MediumOrthogonal Signal CorrectionPerformance MetricsSavitzky-Golay

Identifiers

PMID41783479
PMCPMC12954738

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.